Hester Biosciences
BSE:524669
Rp 1.318,95
Rp-62,50 (-4,52%)
1.318,95 Rp
Rp-62,50 (-4,52%)
End-of-day quote: 03/27/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

Rp32,96
Earnings Per Share
Rp312,68
Revenue Per Share
70,29%
Gross Margin %
Rp11,22 B
Market Cap
Rp1,33 B
Long-Term Debt
Earnings Per Share
Rp32,96
Revenue Per Share
Rp312,68
Gross Margin %
70,29%
Market Cap
Rp11,22 B
Long-Term Debt
Rp1,33 B

Financials

Year Year 2025 2024 2023 2022 2021 2014
EPS Earnings Per Share Rp32,96 Rp32,96 Rp32,96 Rp46,41 Rp43,51 Rp11,11
Earnings Earnings Rp280,49M Rp280,49M Rp280,49M Rp394,95M Rp370,27M Rp94,55M
RPS Revenue Per Share Rp312,68 Rp312,68 Rp312,68 Rp276,15 Rp251,86 Rp0,00
Revenue Revenue Rp2,66B Rp2,66B Rp2,66B Rp2,35B Rp2,14B Rp0,00M
OCF Operating Cash Flow Rp235,96M Rp235,96M Rp235,96M Rp88,08M Rp0,00M Rp0,00M
FCF Free Cash Flow Rp0,00M Rp0,00M Rp-541,66M Rp-869,02M Rp0,00M Rp0,00M
OM Operating Margin 14,60% 13,86% 15,11% 22,32% 27,16% 28,97%
GM % Gross Margin % 70,29% 67,95% 70,35% 72,50% 75,79% 68,21%
FCFS Free Cash Flow Per Share Rp51,63 Rp27,96 Rp-63,67 Rp-102,27 Rp20,35 Rp-4,40
LT Debt Long-Term Debt Rp1,33B Rp1,82B Rp1,85B Rp1,64B Rp825,03M Rp151,91M
Sha. Stocks 8,51M 8,51M 8,51M 8,51M 8,51M 8,51M
×